Tivic Health Systems, Inc. is a commercial health tech company advancing the field of bioelectronic medicine. The Company’s patented technology platform leverages stimulation on the trigeminal, sympathetic, and vagus nerve structures. Its non-invasive and targeted approach to the treatment of inflammatory chronic health conditions is intended to give consumers and providers drug-free therapeutic solutions with high safety profiles, low risk, and broad applications. The Company’s commercial product, ClearUP, is an FDA approved handheld bioelectronic sinus device. ClearUP is clinically proven, doctor-recommended, and available through online retailers and commercial distributors. ClearUP is sold in the United States directly to consumers on various platforms and through reseller channels. The Company is also focused on its intellectual property (IP) portfolio and research programs related to vagus nerve stimulation to expand its applications in non-invasive bioelectronic medicine.
企業コードTIVC
会社名Tivic Health Systems Inc
上場日Nov 11, 2021
最高経営責任者「CEO」Ms. Jennifer Ernst
従業員数7
証券種類Ordinary Share
決算期末Nov 11
本社所在地47685 Lakeview Blvd
都市FREMONT
証券取引所NASDAQ Capital Market Consolidated
国United States of America
郵便番号94538
電話番号18882766888
ウェブサイトhttps://tivichealth.com/
企業コードTIVC
上場日Nov 11, 2021
最高経営責任者「CEO」Ms. Jennifer Ernst
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし